Old Web
English
Sign In
Acemap
>
authorDetail
>
R Verjee
R Verjee
Alternative medicine
Multiple sclerosis
Physical therapy
Cladribine
CLARITY
4
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Consistent efficacy of cladribine tablets across multiple sclerosis and patient characteristics, in the double-blind, 96-week CLARITY study
2010
Peter Rieckmann
G. Comi
Stuart D. Cook
Gavin Giovannoni
K Rammohan
Per Soelberg Sørensen
P. Vermersch
P Chang
A Hamlett
R Verjee
B Musch
Steven J. Greenberg
Show All
Source
Cite
Save
Citations (1)
Disease-free status achieved with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study in patients with relapsing-remitting multiple sclerosis
2009
Gavin Giovannoni
G. Comi
Stuart D. Cook
K Rammohan
Peter Rieckmann
Per Soelberg Sørensen
P. Vermersch
P Chang
A Hamlett
B Musch
R Verjee
T Fevr
Viglietta
Steven J. Greenberg
Show All
Source
Cite
Save
Citations (1)
Rapid and sustained efficacy with cladribine tablet treatment in relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96-week, phase III, double-blind, placebo-controlled trial
2009
P. Vermersch
G. Comi
Stuart D. Cook
Gavin Giovannoni
K Rammohan
Peter Rieckmann
P Soelberg-Sorensen
P Chang
A Hamlett
B Musch
R Verjee
Steven J. Greenberg
Show All
Source
Cite
Save
Citations (1)
Early onset of effect of treatment with cladribine tablets for relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study
2009
P. Vermersch
G. Comi
Stuart D. Cook
Gavin Giovannoni
K Rammohan
Peter Rieckmann
Per Soelberg Sørensen
P Chang
A Hamlett
B Musch
R Verjee
Steven J. Greenberg
Show All
Source
Cite
Save
Citations (4)
1